Aldeyra Therapeutics, Inc.
ALDX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001341235
No open-market purchases or sales by Aldeyra Therapeutics, Inc. insiders were filed in the last 90 days; 107 institutions reported holding it in 13F filings for Q2 2026, worth $77.7M in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in Aldeyra Therapeutics, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 101
- −4 vs. Q4 2023
- Shares held
- 35.4M
- +287.7K (+0.8%) vs. Q4 2023
- Total value
- $115.8M
- −$7.48M (−6.1%) vs. Q4 2023
- New holders
- 14
- 31 more added
- Sold out
- 18
- 33 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ALDX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 107 | $77.7M |
| Q1 2026 | 128 | $63.3M |
| Q4 2025 | 136 | $201.8M |
| Q3 2025 | 131 | $204.2M |
| Q2 2025 | 122 | $130.8M |
| Q1 2025 | 126 | $215.5M |
| Q4 2024 | 119 | $185.6M |
| Q3 2024 | 112 | $196.4M |
| Q2 2024 | 103 | $116.9M |
| Q1 2024 | 101 | $115.8M |
| Q4 2023 | 105 | $123.3M |
| Q3 2023 | 120 | $252.3M |
| Q2 2023 | 119 | $327.5M |
| Q1 2023 | 109 | $353.4M |
| Q4 2022 | 96 | $237.9M |
| Q3 2022 | 89 | $197.4M |
| Q2 2022 | 95 | $147.5M |
| Q1 2022 | 111 | $171.8M |
| Q4 2021 | 115 | $146.7M |
| Q3 2021 | 117 | $348.9M |
| Q2 2021 | 136 | $512.8M |
| Q1 2021 | 108 | $376.7M |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Aldeyra Therapeutics, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Perceptive Advisors LLC | 8,593,586 | $28.1M | 0.50% | 00.0% | Unchanged |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −68,327−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −57,146−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −44,826−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −25,354−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −21,560−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −18,720−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −15,629−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −15,294−100.0% | Sold out |
| Cetera Advisor Networks LLC | 0 | $0 | 0.00% | −14,594−100.0% | Sold out |
| State Board of Administration of Florida Retirement System | 0 | $0 | 0.00% | −13,480−100.0% | Sold out |
| Stifel Financial Corp | 0 | $0 | 0.00% | −13,026−100.0% | Sold out |
| Allspring Global Investments Holdings, LLC | 0 | $0 | 0.00% | −12,189−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −12,138−100.0% | Sold out |
| NorthRock Partners, LLC | 0 | $0 | 0.00% | −11,951−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −11,028−100.0% | Sold out |
| CIBC World Markets Inc. | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Advisory Services Network, LLC | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −243−100.0% | Sold out |